Cardio Diagnostics Holdings, Inc. (CDIO) Documents: SEC Filings, Investor Presentations & Press Releases

Cardio Diagnostics Holdings, Inc. (CDIO) documents, SEC filings and the IR site together: 75 documents, newest first; latest 2026-08-20. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-208-KForm 8-K, Item 7.01
2026-08-19DeckCompany Update 2026
2026-08-0710-QForm 10-Q for the quarter ended Jun 30
2026-08-05Press releaseCardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
2026-08-05Press releaseCardio Diagnostics, Inc. CHICAGO - Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) ("Cardio Diagnostics" or the "Company"), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, today announced that it will host an investor conference call on Thursday, August 20, 2026, at 3 p.m. Central Time
2026-08-05ProxyDefinitive proxy statement
2026-05-1510-QForm 10-Q for the quarter ended Mar 31
2026-03-1310-KAnnual report on Form 10-K, FY25
2026-02-198-KForm 8-K, Item 7.01
2026-02-18Press releaseCORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026
2026-02-17Press releaseCardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026
2026-02-17Press releaseCORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026
2026-02-17Press releaseCardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026
2025-11-1210-QForm 10-Q for the quarter ended Sep 30
2025-10-158-KForm 8-K, Item 5.07
2025-09-04ProxyDefinitive proxy statement
2025-08-1410-QForm 10-Q for the quarter ended Jun 30
2025-05-288-KForm 8-K, Item 8.01
2025-05-1510-QForm 10-Q for the quarter ended Mar 31
2025-05-138-KForm 8-K, Item 3.03
2025-03-2010-KAnnual report on Form 10-K, FY24
2025-02-218-KForm 8-K, Item 7.01
2024-12-048-KForm 8-K, Item 3.01
2024-11-22SEC filingForm S-1
2024-11-188-KForm 8-K, Item 5.07
2024-11-1310-QForm 10-Q for the quarter ended Sep 30
2024-10-04ProxyDefinitive proxy statement
2024-08-1210-QForm 10-Q for the quarter ended Jun 30
2024-06-078-KForm 8-K, Item 3.01
2024-05-1510-QForm 10-Q for the quarter ended Mar 31
2024-04-028-KForm 8-K, Item 7.01
2024-04-0110-KAnnual report on Form 10-K, FY23
2024-02-028-KForm 8-K, Item 3.02
2024-02-018-KForm 8-K, Item 1.01
2024-01-048-KForm 8-K, Item 1.02
2023-12-198-KForm 8-K, Item 5.07
2023-12-068-KForm 8-K, Item 8.01
2023-11-228-KForm 8-K, Item 3.01
2023-11-1310-QForm 10-Q for the quarter ended Sep 30
2023-10-27ProxyDefinitive proxy statement

CDIO overview · CDIO earnings · CDIO financials · CDIO KPIs · CDIO ownership · CDIO peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.